GSTM1 and prostate carcinoma: Using subjects with homozygous deletion of both GSTM1 and GSTT1 genes as the reference group, adjusted models indicated that subjects carrying both genes were at significantly higher risk of prostate cancer (OR: 1.88, 95% CI: 1.11–3.21).